Cardiometabolic Function in Offspring, Mother and Placenta After Assisted Reproductive Technology

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-40
SponsorRigshospitalet, Denmark

About this trial

The overall objective is to establish the first-of-its-kind longitudinal cohort of pregnant women, biological fathers/partners and offspring from pregnancies achieved by frozen embryo transfer (FET), fresh-embryo transfer (fresh ET) and naturally conceived (NC) to investigate maternal cardiometabolic profiles, fetal growth patterns and placental function during pregnancy as well as metabolic and endocrine health in the offspring. Additionally, the aim is to explore genetic and epigenetic patterns in placenta, fetus and parents. As secondary objectives, the investigator group will examine telomere length and minipuberty hormones in children born after FET, fresh-ET and NC.

Eligibility criteria

Qualifiers

None

Disqualifiers

Maternal pregestational diabetes type 1 or 2

Non-singleton pregnancies

Maternal pregestational BMI > 35 kg/m2

Severe maternal co-morbidity

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

600 Participants
are grouped into 3 trial groups

Sponsors and collaborators

Rigshospitalet, Denmark

Lead sponsor

Herlev Hospital

Collaborator